在血管压缩剂依赖的低血压中,宁水平和 ангиотензин II 的反应性
Emily J See1,2,3,4,5,6,7,8, Anis Chaba1, Sofia Spano1
1Department of Intensive Care, Austin Hospital, Heidelberg, VIC, Australia.
Critical care medicine
|March 21, 2024
概括
雷宁- ангиотензин系统 (RAS) 抑制剂的使用增加了基线雷宁水平,降低了严重病患者的血管激素II (ANGII) 反应能力. 尽管进行了ANGII输液,但较高的宁水平与更糟糕的结果相关,突出了宁.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 腎臟醫學 腎臟醫學
背景情况:
- 血管扩张性低血压是一个关键的情况,需要血管压缩剂.
- 氨酸-血管氨系统 (RAS) 在血压调节中起着关键作用.
- RAS抑制剂对低血压中的宁水平和血管激素II (ANGII) 响应性的影响尚不清楚.
研究的目的:
- 为了研究RAS抑制剂暴露,基线蛋白水平和ANGII响应之间的关系.
- 为了确定基线素水平是否预测血管扩张性低血压患者的ANGII反应.
- 检查接受ANGII的患者在24小时内蛋白水平和临床结果之间的关联.
主要方法:
- 在一个学术ICU的前性观察研究.
- 包括40名患有危急病的成年人,患有血管压缩剂依赖的血管扩张性低血压,接受ANGII.
- 在ANGII启动后24小时测量了基线雷宁水平,ANGII反应能力和雷宁水平.
主要成果:
- 暴露于RAS抑制剂与基线氨酸水平增加198%有关.
- 较高的基线氨酸水平预测了增加的ANGII需求 (46%的增加每增加十倍).
- 24小时内蛋白水平升高与存活日数减少和不需要连续置换疗法 (CRRT) 相关.
结论:
- 最近使用RAS抑制剂可使血管扩张性低血压患者的基线蛋白水平升高.
- 较高的蛋白水平与 ANGII 响应能力的降低和较差的临床结果有关.
- 在RAS背景下,宁可以作为管理血管扩张性低血压的关键生物标志物.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
627
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
627
01:25Antihypertensive Drugs: Direct Renin Inhibitors
616
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
616
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
720
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
720
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
01:33Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
01:18Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K